Emerging markets (EM) continue to struggle with their economic recovery. Though their growth forecasts have improved, it is critical that they maintain a steady pace of vaccinations if their economies are to recover fully. The situation is complicated by the swift recovery of the global economy, which has forced many EMs to tighten their monetary policy in the face of inflation pressure. Should investors be wary of exposing their portfolio to volatility too early, or is now the time to look behind the early success of the US market?